Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Director departure
Appointed director
CC transcript
Inv. presentation
Acq. announced

Imunon, Inc. (CLSN) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Quarterly results
Docs: "IMUNON Reports Second Quarter 2023 Financial Results and Provides Business Update"
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Quarterly results
Docs: "IMUNON Reports First Quarter 2023 Financial Results and Provides Business Update"
03/30/2023 10-K Annual Report for the period ended December 31, 2022
03/30/2023 8-K Quarterly results
03/24/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "RESTATED CERTIFICATE OF INCORPORATION OF IMUNON, INC."
03/21/2023 4 Braun Donald P (Director) has filed a Form 4 on Imunon, Inc.
Txns: Granted 2,000 options to buy @ $0
03/21/2023 4 Chow Pok Yu Augustine (Director) has filed a Form 4 on Imunon, Inc.
Txns: Granted 2,000 options to buy @ $0
03/21/2023 4 Fritz Frederick J. (Director) has filed a Form 4 on Imunon, Inc.
Txns: Granted 2,000 options to buy @ $0
03/21/2023 4 Pellizzari Christine A (Director) has filed a Form 4 on Imunon, Inc.
Txns: Granted 2,000 options to buy @ $0
03/21/2023 4 Dentzer James E (Director) has filed a Form 4 on Imunon, Inc.
Txns: Granted 2,000 options to buy @ $0
03/21/2023 4 Lindborg Stacy (Director) has filed a Form 4 on Imunon, Inc.
Txns: Granted 2,000 options to buy @ $0
03/21/2023 4 Tardugno Michael H (Executive Chairman of Board) has filed a Form 4 on Imunon, Inc.
Txns: Granted 25,000 options to buy @ $0
03/21/2023 4 Anwer Khursheed (Chief Scientific Officer) has filed a Form 4 on Imunon, Inc.
Txns: Granted 40,000 options to buy @ $0
03/21/2023 4 CHURCH JEFFREY WAYNE (CFO) has filed a Form 4 on Imunon, Inc.
Txns: Granted 40,000 options to buy @ $0
03/21/2023 4 Le Goff Corinne (President and CEO) has filed a Form 4 on Imunon, Inc.
Txns: Granted 90,000 options to buy @ $0
02/10/2023 8-K Quarterly results
01/03/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/15/2022 8-K Quarterly results
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/14/2022 8-K Quarterly results
Docs: "IMUNON Reports Third Quarter 2022 Financial Results and Provides Business Update"
10/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/03/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
10/03/2022 8-K Quarterly results
09/19/2022 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION OF CELSION CORPORATION Celsion Corporation , a corporation organized and existing under the General Corporation Law of the State of Delaware , does hereby certify that: FIRST: The name of the Corporation is Celsion Corporation. SECOND: The original Certificate of Incorporation of the Corporation Corporation) was filed with the Secretary of State of the State of Delaware on May 17, 2000, a Certificate of Ownership and Merger was thereafter filed with the Secretary of State of the State of Delaware on August 17, 2000, and certificates of Amendment to Certificate of Incorporation were thereafter filed with the Secretary of State of the State of Delaware on June 5, 2001, November 8, 2002, May 25, 2004, February 27, 2006, July 1, 2009, Oc...",
"CERTIFICATE OF ELIMINATION OF SERIES A CONVERTIBLE REDEEMABLE PREFERRED STOCK AND SERIES B CONVERTIBLE REDEEMABLE PREFERRED STOCK OF CELSION CORPORATION Pursuant to Section 151 of the General Corporation Law of the State of Delaware",
"Certificate of Incorporation",
"Celsion Corporation Announces Company Name Change to Imunon, Inc."
08/15/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/15/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/15/2022 8-K Quarterly results
07/20/2022 4 Le Goff Corinne (President and CEO) has filed a Form 4 on Celsion CORP
Txns: Granted 53,000 shares @ $0
Granted 177,000 options to buy @ $1.95, valued at $345.2k
07/20/2022 3 Le Goff Corinne (President and CEO) has filed a Form 3 on Celsion CORP
07/19/2022 8-K Quarterly results
06/15/2022 4 Kardaras Constantine John (Chief Accounting Officer) has filed a Form 4 on Celsion CORP
Txns: Granted 1,750 options to buy @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy